Risk of estrogen-driven malignancies in females on 5-alpha reductase inhibitors.

Publication/Presentation Date

11-26-2024

Volume

317

Issue

1

First Page

46

Last Page

46

ISSN

1432-069X

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

39589522

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS